Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Blood Advances
|
May 16, 2019
Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib
Farrukh T Awan, Anna Schuh, Jennifer R Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2020
Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response
Ben Sidders, Pei Zhang, Kelly Goodwin, et al.
Journal of the American Society of Nephrology : JASN
|
May 21, 2013
LMX1B mutations cause hereditary FSGS without extrarenal involvement
Olivia Boyer, Stéphanie Woerner, Fan Yang, et al.
Journal for Immunotherapy of Cancer
|
July 31, 2020
Small molecule AZD4635 inhibitor of A<sub>2A</sub>R signaling rescues immune cell function including CD103<sup>+</sup> dendritic cells enhancing anti-tumor immunity
Alexandra Borodovsky, Christine M Barbon, Yanjun Wang, et al.
American Journal of Human Genetics
|
May 2, 2017
Duplicated Enhancer Region Increases Expression of CTSB and Segregates with Keratolytic Winter Erythema in South African and Norwegian Families
Thandiswa Ngcungcu, Martin Oti, Jan C Sitek, et al.
Nature Communications
|
October 22, 2015
Mutations in TRAF3IP1/IFT54 reveal a new role for IFT proteins in microtubule stabilization
Albane A Bizet, Anita Becker-Heck, Rebecca Ryan, et al.
American Journal of Human Genetics
|
January 17, 2017
Mutations in MAPKBP1 Cause Juvenile or Late-Onset Cilia-Independent Nephronophthisis
Maxence S Macia, Jan Halbritter, Marion Delous, et al.
American Journal of Human Genetics
|
February 4, 2017
Mutations in MAPKBP1 Cause Juvenile or Late-Onset Cilia-Independent Nephronophthisis
Maxence S Macia, Jan Halbritter, Marion Delous, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Blood Advances
|
May 16, 2019
Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib
Farrukh T Awan, Anna Schuh, Jennifer R Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2020
Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response
Ben Sidders, Pei Zhang, Kelly Goodwin, et al.
Journal of the American Society of Nephrology : JASN
|
May 21, 2013
LMX1B mutations cause hereditary FSGS without extrarenal involvement
Olivia Boyer, Stéphanie Woerner, Fan Yang, et al.
Journal for Immunotherapy of Cancer
|
July 31, 2020
Small molecule AZD4635 inhibitor of A<sub>2A</sub>R signaling rescues immune cell function including CD103<sup>+</sup> dendritic cells enhancing anti-tumor immunity
Alexandra Borodovsky, Christine M Barbon, Yanjun Wang, et al.
American Journal of Human Genetics
|
May 2, 2017
Duplicated Enhancer Region Increases Expression of CTSB and Segregates with Keratolytic Winter Erythema in South African and Norwegian Families
Thandiswa Ngcungcu, Martin Oti, Jan C Sitek, et al.
Nature Communications
|
October 22, 2015
Mutations in TRAF3IP1/IFT54 reveal a new role for IFT proteins in microtubule stabilization
Albane A Bizet, Anita Becker-Heck, Rebecca Ryan, et al.
American Journal of Human Genetics
|
January 17, 2017
Mutations in MAPKBP1 Cause Juvenile or Late-Onset Cilia-Independent Nephronophthisis
Maxence S Macia, Jan Halbritter, Marion Delous, et al.
American Journal of Human Genetics
|
February 4, 2017
Mutations in MAPKBP1 Cause Juvenile or Late-Onset Cilia-Independent Nephronophthisis
Maxence S Macia, Jan Halbritter, Marion Delous, et al.
Page
of 2